Literature DB >> 10193747

Mechanism of arrhythmogenicity of the short-long cardiac sequence that precedes ventricular tachyarrhythmias in the long QT syndrome.

N El-Sherif1, E B Caref, M Chinushi, M Restivo.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the electrophysiologic mechanism(s) that underlie the transition of one or more short-long (S-L) cardiac sequences to ventricular tachyarrhythmias (VTs) in the long QT syndrome.
BACKGROUND: One or more S-L cardiac cycles, usually the result of a ventricular bigeminal rhythm, frequently precedes the onset of VT in patients with either normal or prolonged QT interval. Electrophysiologic mechanisms that underlie this relationship have not been fully explained.
METHODS: We investigated electrophysiologic changes associated with the transition of a S-L cardiac sequence to VT in the canine anthopleurin-A model, a surrogate of LQT3. Experiments were performed on 12 mongrel puppies after administration of anthopleurin-A. Correlation of tridimensional activation and repolarization patterns was obtained from up to 384 electrograms. Activation-recovery intervals were measured from unipolar electrograms and were considered to represent local repolarization.
RESULTS: We analyzed 24 different episodes of a S-L sequence that preceded VT obtained from 12 experiments. The VT followed one S-L sequence (five episodes), two to five S-L sequences (12 episodes) and more than five S-L sequences (seven episodes). The single premature ventricular beats coupled to the basic beats were consistently due to a subendocardial focal activity (SFA). There were two basic mechanisms for the development of VT after one or more S-L sequences: 1) in 10 examples of a S-L sequence due to a stable unifocal bigeminal rhythm, the occurrence of a second SFA, which arose consistently from a different site, infringed on the pattern of dispersion of repolarization (DR) of the first SFA to initiate reentrant excitation; 2) in the remaining 14 episodes of a S-L sequence, a slight lengthening (50 to 150 ms) in one or more preceding cycle lengths (CLs) resulted in alterations of the spatial pattern of DR at key sites to promote reentry. The lengthening of the preceding CL produced differentially a greater degree of prolongation of repolarization at midmyocardial and endocardial sites compared with epicardial sites with consequent increase of DR. The increased DR at key adjacent sites resulted in the development of de novo zones of functional conduction block and/or slowed conduction to create the necessary prerequisites for successful reentry.
CONCLUSIONS: The occurrence of VT after one or more S-L cardiac sequences was due to well defined electrophysiologic changes with predictable consequences that promoted reentrant excitation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10193747     DOI: 10.1016/s0735-1097(98)00700-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

Review 1.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis.

Authors:  Charles Antzelevitch; Luiz Belardinelli
Journal:  J Cardiovasc Electrophysiol       Date:  2006-05

Review 3.  Pharmacogenetic issues in thorough QT trials.

Authors:  Richard S Judson; Benjamin A Salisbury; Carol R Reed; Michael J Ackerman
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 4.  Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent?

Authors:  S Viskin; R Fish; D Zeltser; B Belhassen; K Heller; D Brosh; S Laniado; H V Barron
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

Review 5.  Drug-induced QT interval prolongation: mechanisms and clinical management.

Authors:  Senthil Nachimuthu; Manish D Assar; Jeffrey M Schussler
Journal:  Ther Adv Drug Saf       Date:  2012-10

Review 6.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

7.  Conditional ablation and conditional rescue models for Casq2 elucidate the role of development and of cell-type specific expression of Casq2 in the CPVT2 phenotype.

Authors:  Daniel J Flores; ThuyVy Duong; Luke O Brandenberger; Apratim Mitra; Aditya Shirali; John C Johnson; Danielle Springer; Audrey Noguchi; Zu-Xi Yu; Steven N Ebert; Andreas Ludwig; Bjorn C Knollmann; Mark D Levin; Karl Pfeifer
Journal:  Hum Mol Genet       Date:  2018-05-01       Impact factor: 6.150

8.  Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.

Authors:  Enrique G Navarrete; Ping Liang; Feng Lan; Verónica Sanchez-Freire; Chelsey Simmons; Tingyu Gong; Arun Sharma; Paul W Burridge; Bhagat Patlolla; Andrew S Lee; Haodi Wu; Ramin E Beygui; Sean M Wu; Robert C Robbins; Donald M Bers; Joseph C Wu
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

9.  An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.

Authors:  Stefan Dhein; Franziska Perlitz; Friedrich-Wilhelm Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-22       Impact factor: 3.000

10.  Sodium overload due to a persistent current that attenuates the arrhythmogenic potential of a novel LQT3 mutation.

Authors:  Adrien Moreau; Andrew D Krahn; Pascal Gosselin-Badaroudine; George J Klein; Georges Christé; Yohann Vincent; Mohamed Boutjdir; Mohamed Chahine
Journal:  Front Pharmacol       Date:  2013-10-01       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.